This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Relay Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jethro Beamish-Cook: Innovator in FGFR Inhibitors
Introduction
Jethro Beamish-Cook is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His work is characterized by a focus on innovative methods and compounds that have the potential to impact medical treatments.
Latest Patents
Jethro holds a patent for "FGFR inhibitors and methods of making and using the same." This patent is directed in part to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide. The patent also covers its salts, cocrystals, and variants thereof. He has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Jethro is currently employed at Relay Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical research. His work at the company emphasizes the importance of targeted therapies in treating various diseases.
Collaborations
He collaborates with talented individuals such as André Lescarbeau and Zoe Prentice, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jethro Beamish-Cook is a prominent figure in the field of FGFR inhibitors, with a focus on developing new methods and compounds that can lead to significant advancements in medical treatments. His contributions are paving the way for future innovations in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile